AF
SGMO

Amalgamated Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Amalgamated Financial’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$109K Buy
+18,807
New +$112K ﹤0.01% 2116

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Financial's SGMO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q1 2022: 18,807 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #2116 among its holdings.

195 funds tracked by Wall St. Rank hold SGMO as of Q1 2022.

  • Amalgamated Financial held 18,807 shares of SANGAMO THERAPEUTICS INC worth $109K as of Q1 2022.
  • SANGAMO THERAPEUTICS INC was a new Amalgamated Financial position in Q1 2022.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2116 holding.
  • 195 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.